TG Therapeutics
TGTX
TGTX
146 hedge funds and large institutions have $639M invested in TG Therapeutics in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 46 increasing their positions, 45 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+11
Holders Change %
+8.15%
% of All Funds
3.23%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
34
Increased
46
Reduced
45
Closed
20
Calls
$40.5M
Puts
$8.37M
Net Calls
+$32.1M
Net Calls Change
+$4.48M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$93.7M |
| 2 |
EP
Eversept Partners
New York
|
$24.2M |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
$12.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$21.5M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
$9.31M |
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$25.2M |
| 2 |
Millennium Management
New York
|
$10.7M |
| 3 |
BM
Bridger Management
New York
|
$8.35M |
| 4 |
Renaissance Technologies
New York
|
$5.04M |
| 5 |
D.E. Shaw & Co
New York
|
$2.77M |
